MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 12-16-2023
Cerner Corporation DSO Ratio 2011-2025 | CERN
Annual DSO Ratio Cerner Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 73.8 | 76.5 | 74.5 | 75.7 | 70.5 | 85.3 | 72.2 | - | 73.1 | 79.1 | 94.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 94.1 | 70.5 | 77.5 |
Quarterly DSO Ratio Cerner Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 74.7 | - | 76.4 | 75.5 | 77.1 | 76.5 | 77.9 | 80.2 | 74.6 | 72.1 | 72.8 | 72.7 | 76.3 | 79.1 | 80.6 | 79 | 78.6 | 72.4 | 74.6 | 73.7 | 72 | 68.5 | 72.8 | 70.9 | 64.8 | 85 | 83.2 | 78.8 | 43.1 | - | 66.9 | 63.1 | 66.7 | 66.9 | 73.1 | 75.2 | 77.9 | 74.2 | 78 | 82.7 | 81.2 | 83.5 | 89.9 | 98 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 98 | 43.1 | 75.3 |
DSO Ratio of other stocks in the Health information services industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Covetrus
CVET
|
39.4 | - | - | $ 2.94 B |  USA |
 |
Computer Programs and Systems
CPSI
|
59.7 | - | 4.4 % | $ 133 M | USA |
 |
Accolade
ACCD
|
9.76 | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
79 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
144 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
94.4 | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
127 | - | - | $ 102 M | USA |
 |
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | USA |
 |
Evolent Health
EVH
|
210 | $ 4.09 | -0.97 % | $ 383 M | USA |
 |
Health Catalyst
HCAT
|
69.9 | $ 2.51 | 3.51 % | $ 151 M | USA |
 |
HealthStream
HSTM
|
40.4 | $ 23.24 | -1.59 % | $ 706 M | USA |
 |
MTBC
MTBC
|
40.6 | - | -0.58 % | $ 51.7 M | USA |
 |
Akerna Corp.
KERN
|
7.62 | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
140 | $ 92.73 | -0.8 % | $ 7.93 B | USA |
 |
Progyny
PGNY
|
292 | $ 25.6 | -0.78 % | $ 2.2 B | USA |
 |
American Well Corporation
AMWL
|
90.4 | $ 4.59 | 0.55 % | $ 68.8 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
81.9 | - | -10.39 % | $ 886 M | USA |
 |
OptimizeRx Corporation
OPRX
|
149 | $ 12.24 | -1.92 % | $ 210 M | USA |
 |
Schrödinger
SDGR
|
265 | $ 17.87 | -2.4 % | $ 1.3 B | USA |
 |
So-Young International
SY
|
-6.34 K | $ 2.5 | -4.94 % | $ 198 M |  China |
 |
GoodRx Holdings
GDRX
|
66.7 | $ 2.7 | -1.82 % | $ 1.04 B | USA |
 |
Omnicell
OMCL
|
83.4 | $ 46.28 | -0.26 % | $ 2.13 B | USA |
 |
1Life Healthcare
ONEM
|
50.2 | - | - | $ 3.37 B | USA |
 |
Phreesia
PHR
|
59.5 | $ 16.93 | -0.38 % | $ 924 M | USA |
 |
Premier
PINC
|
139 | $ 28.26 | - | $ 2.33 B | USA |
 |
10x Genomics
TXG
|
64.6 | $ 16.13 | -2.21 % | $ 1.89 B | USA |
 |
R1 RCM
RCM
|
27.5 | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
32 | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
51.6 | - | - | $ 1.6 B | USA |
 |
Zhongchao
ZCMD
|
116 | $ 0.42 | -17.6 % | $ 2.19 M | China |
 |
Signify Health
SGFY
|
272 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
30.7 | $ 6.93 | -2.74 % | $ 1.18 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
24.8 | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
120 | $ 224.73 | 0.04 % | $ 36.1 B | USA |
 |
SCWorx Corp.
WORX
|
41.4 | $ 0.2 | -3.56 % | $ 292 K | USA |